Science to Practice: Are Theranostic Agents with Encapsulated Cells the Key for Diabetes Therapy?KIESSLING, Fabian M.Radiology. 2011, Vol 260, Num 3, pp 613-615, issn 0033-8419, 3 p.Article

Sensors and imaging for wound healing: A reviewDARGAVILLE, Tim R; FARRUGIA, Brooke L; BROADBENT, James A et al.Biosensors & bioelectronics. 2013, Vol 41, pp 30-42, issn 0956-5663, 13 p.Article

Exosomes as Immunotheranostic Nanoparticles : EXTRACELLULAR EXOSOMES AND MICROVESICLES IN ALLERGIC AND IMMUNOLOGICAL DISEASESNATASHA, G; GUNDOGAN, Buket; AARON TAN et al.Clinical therapeutics. 2014, Vol 36, Num 6, pp 820-829, issn 0149-2918, 10 p.Article

Synthetic immunosurveillance systems: Nanodevices to monitor physiological eventsWOAPPI, Yvon L; JANGITI, Rahul; SINGH, Om V et al.Biosensors & bioelectronics. 2014, Vol 61, pp 152-164, issn 0956-5663, 13 p.Article

Sulfonates-PMMA nanoparticles conjugates: A versatile system for multimodal applicationMONASTEROLO, Claudio; BALLESTRI, Marco; ZUNINO, Franco et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 22, pp 6640-6647, issn 0968-0896, 8 p.Article

Patent Eligibility of Induced Pluripotent Stem Cell TheranosticsTRILLER VRTOVEC, K; VRTOVEC, B.Clinical pharmacology and therapeutics. 2013, Vol 93, Num 4, pp 318-320, issn 0009-9236, 3 p.Article

Pharmacogenomics and theranostics in practiceDrug metabolism and drug interactions. 2013, Vol 28, Num 1, issn 0792-5077, A1-A13 [12 p.]Conference Paper

Nanomaterials for Photohyperthermia: A ReviewFANG, Jonathan; CHEN, Yu-Chie.Current pharmaceutical design (Print). 2013, Vol 19, Num 37, pp 6622-6634, issn 1381-6128, 13 p.Article

Personalized Medicine: how to Switch from the Concept to the Integration into the Clinical Development Plan to Obtain Marketing AuthorizationBECQUEMONT, Laurent; BORDET, Régis; CELLIER, Dominic et al.Thérapie (Paris). 2012, Vol 67, Num 4, pp 349-357, issn 0040-5957, 9 p.Article

Bifunctional Chelators in the Design and Application of Radiopharmaceuticals for Oncological DiseasesSARKO, D; EISENHUT, M; HABERKORN, U et al.Current medicinal chemistry. 2012, Vol 19, Num 17, pp 2667-2688, issn 0929-8673, 22 p.Article

Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity ConcernAKHTER, Sohail; MOHAMMAD ZAKI AHMAD; SINGH, Anjali et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 18, pp 1834-1850, issn 1381-6128, 17 p.Article

Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies—A reviewMIGUEL OLIVEIRA, Joaquim; SALGADO, António José; SOUSA, Nuno et al.Progress in polymer science. 2010, Vol 35, Num 9, pp 1163-1194, issn 0079-6700, 32 p.Article

Peptide-based targeting strategies for simultaneous imaging and therapy with nanovectors : Peptide MaterialsACCARDO, Antonella; TESAURO, Diego; MORELLI, Giancarlo et al.Polymer journal. 2013, Vol 45, Num 5, pp 481-493, issn 0032-3896, 13 p.Article

Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional PlatformsFERNANDEZ-FERNANDEZ, Alicia; MANCHANDA, Romila; MCGORON, Anthony J et al.Applied biochemistry and biotechnology. 2011, Vol 165, Num 7-8, pp 1628-1651, issn 0273-2289, 24 p.Article

Compte-rendu et analyse du 48^e congrès américain en cancérologie Chicago///1er-5 juin 2012MORERE, Jean-François.La Lettre du cancérologue (Boulogne). 2012, Vol 21, Num 6, issn 1165-113X, 75 p., SUP2Serial Issue

Cancer theranostics: the rise of targeted magnetic nanoparticlesCOLE, Adam J; YANG, Victor C; DAVID, Allan E et al.Trends in biotechnology (Regular ed.). 2011, Vol 29, Num 7, pp 323-332, issn 0167-7799, 10 p.Article

LES ÉVOLUTIONS EN BIOLOGIE MOLÉCULAIREPIVERT, G.IRBM news. 2010, Vol 31, Num 4, pp 23-25, issn 1959-7568, 3 p.Conference Paper

Atherosclerotic disease and management challenges with nanomedicine: EU FP7 NMP funded NanoAthero and CosmoPHOS-nano large-scale projectsLETOURNEUR, Didier; TROHOPOULOS, Panagiotis N.European journal of nanomedicine (Print). 2014, Vol 6, Num 2, pp 115-119, issn 1662-5986, 5 p.Article

Diffusion of Single-Walled Carbon Nanotube Under Physiological ConditionsJUDKINS, John; HYUN HO LEE; TUNG, Steve et al.Journal of biomedical nanotechnology (Print). 2013, Vol 9, Num 6, pp 1065-1070, issn 1550-7033, 6 p.Article

Nanosized hydroxyapatite and other calcium phosphates: Chemistry of formation and application as drug and gene delivery agentsUSKOKOVIC, Vuk; USKOKOVIC, Dragan P.Journal of biomedical materials research. Part B, Applied biomaterials. 2011, Vol 96, Num 1, pp 152-191, issn 1552-4973, 40 p.Article

Modular theranostic prodrug based on a FRET-activated self-immolative linerREDY, Orit; SHABAT, Doron.Journal of controlled release. 2012, Vol 164, Num 3, pp 276-282, issn 0168-3659, 7 p.Article

Shifting emphasis from pharmacogenomics to theragnosticsOZDEMIR, Vural; WILLIAMS-JONES, Bryn; GLATT, Stephen J et al.Nature biotechnology. 2006, Vol 24, Num 8, pp 942-947, issn 1087-0156, 6 p.Article

Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities : BIOMATERIALSZHILIANG CHENG; AL ZAKI, Ajlan; HUI, James Z et al.Science (Washington, D.C.). 2012, Vol 338, Num 6109, pp 903-910, issn 0036-8075, 8 p.Article

Tumor-Targeting Multifunctional Nanoparticles for siRNA Delivery: Recent Advances in Cancer TherapySOOK HEE KU; KWANGMEYUNG KIM; KUIWON CHOI et al.Advanced healthcare materials (Print). 2014, Vol 3, Num 8, pp 1182-1193, issn 2192-2640, 12 p.Article

Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood―brain barrierFENG YAN; YING WANG; SHENZHI HE et al.Journal of materials science. Materials in medicine. 2013, Vol 24, Num 10, pp 2371-2379, issn 0957-4530, 9 p.Article